FDA Approved: SUCRALFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for sucralfate from Teva Pharmaceuticals USA, Inc., indicating approval of a change to an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Peptic Ulcer Disease

Drugs mentioned

• SUCRALFATE (SUCRALFATE)

Snippet

SUPPL AP for SUCRALFATE (SUCRALFATE)